Executive Summary
On January 8, 2026, 44 8-K filings in the USA S&P 500 Industrials stream revealed predominantly routine disclosures with neutral sentiment, dominated by generic 'Other Events' (Item 8.01), financial results (Item 2.02), and officer changes (Item 5.02), but limited true Industrials exposure amid a broad mix of sectors. Cross-filing patterns highlight clustered executive transitions in electronics/manufacturing firms (e.g., Amphenol, Littelfuse, Transcat, Graphic Packaging) and sparse earnings releases (e.g., RPM International), signaling stable but unremarkable sector dynamics with low materiality overall. Portfolio implications point to minimal near-term volatility for Industrials holdings, though detail gaps underscore need for full filing reviews; no systemic shocks evident.
Tracking the trend? Catch up on the prior S&P 500 Industrials Sector SEC Filings digest from January 06, 2026.
Investment Signals(3)
- ▲
Cluster of officer changes in electronics/components firms (Amphenol, Littelfuse, Transcat, Graphic Packaging) may signal leadership refresh [NEUTRAL-to-BULLISH] - Monitor for succession details
- ▲
RPM International financial results disclosure (Item 2.02) amid quiet earnings start [NEUTRAL] - RPM International
- ▲
General Motors 'Other Events' filing with low materiality [NEUTRAL] - General Motors
Risk Flags(3)
- ▼
Widespread lack of disclosure details across 80%+ of filings limits risk assessment, potentially masking material impacts in Industrials-related names [SYSTEMIC - Data opacity]
- ▼
Executive turnover cluster in key subsectors (electronics/manufacturing) raises governance stability concerns [SECTOR-SPECIFIC - Amphenol, Littelfuse et al.]
- ▼
Non-Industrials bearish outliers (e.g., ImmuCell impairments, urban-gro delisting) highlight small-cap volatility spillover risks to broader market sentiment
Opportunities(3)
- (CROSS-SECTOR)◆
Potential alpha from new material agreements in adjacent firms (e.g., Neuphoria, Catheter Precision), if correlated to Industrials supply chains
- ◆
Early earnings visibility in RPM International could provide sector benchmarking edge for Industrials peers
- ◆
Reg FD disclosures (e.g., Transcat, Amphenol) may contain forward guidance for contrarian positioning in electronics subsector
Sector Themes(3)
- ◆
Executive churn in Industrials electronics/manufacturing (4+ filings: Amphenol, Littelfuse, Transcat, Graphic Packaging), suggesting talent reallocation or succession planning amid stable operations
- ◆
Routine financial/operational disclosures dominate with neutral tone, indicating no broad earnings pressure or catalysts in S&P 500 Industrials on this date
- ◆
High volume of low-detail 'Other Events' + exhibits points to press release cadence, low signal-to-noise for sector trends
Watch List(4)
- 👁
Amphenol, Littelfuse, Transcat, Graphic Packaging - Officer changes + Reg FD; assess leadership impacts and guidance
- 👁
RPM International - Financial results; compare to Industrials peers for Q4 trends
- 👁
urban-gro (delisting notice), ImmuCell (impairments) - Monitor for small-cap distress contagion to Industrials suppliers
- 👁
General Motors - Undisclosed 'Other Events'; potential transportation ripple to sector
Filing Analyses(44)
08-01-2026
GENELUX Corp filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000989, Size: 617 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific other events or financial statements/exhibits are disclosed in the provided filing summary. This is a multi-item filing with sector not specified.
08-01-2026
FARADAY FUTURE INTELLIGENT ELECTRIC INC. filed a Form 8-K on January 08, 2026 (AccNo: 0001213900-26-002315, Size: 281 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the financial statements/exhibits are disclosed in the provided filing summary. This is a multi-item general filing from the US SEC.
08-01-2026
SmartStop Self Storage REIT, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-006699, Size: 146 KB) reporting under Item 7.01 Regulation FD Disclosure. No details on the content of the disclosure, transaction values, financial metrics, or other specifics are provided in the filing summary. Sector is not specified.
08-01-2026
Neuphoria Therapeutics Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001213900-26-002245, size 293 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 1.02 termination of a material definitive agreement, with financial statements and exhibits under Item 9.01. No details on the agreements, parties, values, or impacts are disclosed. This is a multi-item mandatory filing as a material event.
08-01-2026
Catheter Precision, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001437749-26-000839, Size: 287 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, parties, or other terms are disclosed.
08-01-2026
Brookfield Asset Management Ltd. filed a Form 8-K on January 08, 2026 (AccNo: 0001171843-26-000130, Size: 216 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, or exhibits are provided in the filing summary. Sector not specified.
08-01-2026
Global Net Lease, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001104659-26-001919, Size: 292 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the Regulation FD disclosure or specific exhibits are provided. Sector not specified.
08-01-2026
Vanda Pharmaceuticals Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001628280-26-001273, Size: 238 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.
08-01-2026
RPM International Inc./DE/ filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-006976, Size: 472 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a financial results disclosure with no specific revenue, earnings, or other metrics detailed in the provided information. Sector is not specified.
08-01-2026
Amylyx Pharmaceuticals, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-006991, Size: 20 MB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the core events, transactions, financial impacts, or exhibits are disclosed in the provided filing summary. All quantitative financial data, named entities beyond the filer, and event specifics are NOT_DISCLOSED.
08-01-2026
NEOGEN CORP filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-006990, Size: 904 KB) reporting financial results under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a financial results announcement from the US SEC. No specific financial metrics, transaction values, or other quantitative details are disclosed in the provided filing summary.
08-01-2026
Xeris Biopharma Holdings, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001867096-26-000004, Size: 222 KB) reporting under Item 2.02 for Results of Operations and Financial Condition. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. This appears to be a voluntary disclosure of financial results.
08-01-2026
Opus Genetics, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001140361-26-000615, Size: 188 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event, transaction details, financial metrics, or quantitative data are explicitly stated in the provided filing summary. All specific numbers such as transaction values, share counts, or percentages are NOT_DISCLOSED.
08-01-2026
Acuity Inc. (DE) filed a Form 8-K on January 8, 2026 (AccNo: 0001144215-26-000012, Size: 441 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This discloses financial results as a standard earnings-related 8-K. No specific revenue, earnings, transaction values, or other quantitative financial metrics are mentioned.
08-01-2026
Collegium Pharmaceutical, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001104659-26-001953, Size: 9 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or other specific content are disclosed in the provided filing summary. Sector is not specified.
08-01-2026
Transcat Inc filed a Form 8-K on January 8, 2026 (AccNo: 0001206774-26-000020, Size: 285 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified.
08-01-2026
Voyager Therapeutics, Inc. filed an 8-K on January 08, 2026 (AccNo: 0001104659-26-001955, Size: 8 MB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or quantitative data are explicitly stated in the provided filing summary. Sector is not specified.
08-01-2026
Murphy Oil Corp filed a Form 8-K on January 8, 2026 (AccNo: 0000950103-26-000244, Size: 530 KB), reporting under Items 2.04 (Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Off-Balance Sheet Arrangement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific event details, transaction values, or financial metrics provided in the summary. Sector not specified.
08-01-2026
Ardelyx, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001437402-26-000003, Size: 152 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, revenue, earnings, or quantitative impacts are disclosed in the provided filing summary. This appears to be a standard financial results disclosure from the US SEC.
08-01-2026
Atea Pharmaceuticals, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007081, Size: 183 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure event from the US SEC. No specific financial metrics, transaction values, or detailed results are mentioned in the provided filing summary.
08-01-2026
60 Degrees Pharmaceuticals, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001213900-26-002359, Size: 17 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific core event, transaction details, or financial metrics disclosed in the provided summary. Sector is not specified.
08-01-2026
First Northwest Bancorp filed a Form 8-K on January 08, 2026 (AccNo: 0001437749-26-000851, Size: 152 KB), disclosing an officer change under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on the affected individuals, positions, reasons for change, or any quantitative data are provided in the filing summary. Sector is not specified.
08-01-2026
COMMUNITY BANCORP /VT filed a Form 8-K on January 08, 2026 (AccNo: 0001654954-26-000181, size 152 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, financial statements, or exhibits are provided in the filing summary.
08-01-2026
Salarius Pharmaceuticals, Inc. filed a Form 8-K on 2026-01-08 (AccNo: 0001615219-26-000013, Size: 470 KB) reporting under Item 5.03 amendments to Articles of Incorporation or Bylaws or change in fiscal year, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the nature of amendments, events, or exhibits are provided in the filing summary. Sector not specified.
08-01-2026
TruBridge, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007672), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, personnel changes, disclosures, or exhibits provided in the summary. All transaction values, financial metrics, and named entities beyond the filer are NOT_DISCLOSED.
08-01-2026
General Motors Co filed a Form 8-K on January 08, 2026, under Item 8.01 Other Events. Accession number: 0001467858-26-000005; file size: 239 KB. No details on the specific event, transaction, or financial impacts are disclosed.
08-01-2026
Phathom Pharmaceuticals, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001193125-26-007660, Size: 657 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. All quantitative data including transaction values, share counts, percentages, and financial metrics are NOT_DISCLOSED.
08-01-2026
EDUCATIONAL DEVELOPMENT CORP filed a Form 8-K on January 8, 2026 (AccNo: 0001185185-26-000075, Size: 237 KB), disclosing under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This multi-item filing pertains to financial results in the US market. No specific financial metrics, transaction values, or other quantitative data are mentioned.
08-01-2026
Kimball Electronics, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001606757-26-000004, Size: 1 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, or exhibits are provided in the filing summary. Sector not specified.
08-01-2026
Heritage Distilling Holding Company, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001788230-26-000002, Size: 185 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the Regulation FD disclosure content, core event, transaction details, financial statements, or exhibits are provided in the filing summary. Sector is not specified.
08-01-2026
Agenus Inc filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007706, Size: 142 KB), reporting Item 1.01 Entry into a Material Definitive Agreement and Item 3.03 Material Modifications to Rights of Security Holders. No details on the agreement, transaction terms, parties involved, financial values, or specific modifications are disclosed in the provided information. Sector not specified.
08-01-2026
Littelfuse Inc./DE filed an 8-K on January 8, 2026 (AccNo: 0001140361-26-000720, size 194 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reason, or compensation provided in the available information. Sector not specified.
08-01-2026
Graphic Packaging Holding Co filed an 8-K on January 8, 2026 (AccNo: 0001193125-26-007697, Size: 132 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on the officer's name, position, reason for change, or any quantitative data are provided in the available information. Sector is not specified.
08-01-2026
ImmuCell Corp /DE/ filed a Form 8-K on January 8, 2026 (AccNo: 0001437749-26-000885, Size: 217 KB), reporting Items 2.02 (Results of Operations and Financial Condition), 2.06 (Material Impairments), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing material impairments alongside financial results and other events. Specific details including dollar values, transaction sizes, financial metrics, or strategic context are NOT_DISCLOSED.
08-01-2026
Camden National Corp filed a Form 8-K on January 8, 2026 (AccNo: 0000750686-26-000004, size 170 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, or exhibits are disclosed in the provided filing summary. All quantitative financial data and core event descriptions are NOT_DISCLOSED.
08-01-2026
MID PENN BANCORP INC disclosed an officer change via Form 8-K filed on January 08, 2026 (AccNo: 0000879635-26-000007, Size: 494 KB). The filing covers Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, nature of change, reasons, or compensation are provided.
08-01-2026
Calumet, Inc. (/DE) filed Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007783, size: 410 KB), reporting Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing from the US SEC source. No specific details, transaction values, or financial metrics disclosed in the provided summary.
08-01-2026
urban-gro, Inc. filed a Form 8-K on 2026-01-08 (AccNo: 0001213900-26-002552, Size: 194 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No specific details on the delisting trigger, financial impacts, transaction values, or sector are disclosed. This represents a material compliance event with bearish implications for liquidity and valuation.
08-01-2026
KalVista Pharmaceuticals, Inc. filed a Form 8-K on January 8, 2026 (AccNo: 0001193125-26-007801, Size: 2 MB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a financial results disclosure for a US biotech company, but specific revenue, earnings, or other metrics are NOT_DISCLOSED. Sector is not specified.
08-01-2026
INTELLIGENT BIO SOLUTIONS INC. filed a Form 8-K on January 08, 2026 (AccNo: 0001493152-26-000984, Size: 202 KB) under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Sector not specified.
08-01-2026
Amphenol Corp (/DE/) filed a Form 8-K on January 8, 2026 (AccNo: 0001104659-26-002183, Size: 205 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, internal/external status, or quantitative data such as compensation are provided in the summary. Event type is Officer Change; sector not specified.
08-01-2026
Gabelli Dividend & Income Trust filed a Form 8-K on January 8, 2026 (AccNo: 0001829126-26-000118, Size: 242 KB) under Item 8.01 Other Events announcing a dividend. No specific details on dividend amount, record date, ex-dividend date, payment timeline, or eligibility are disclosed. Sector is not specified.
08-01-2026
Guidewire Software, Inc. filed a Form 8-K on January 08, 2026 (AccNo: 0001528396-26-000007, Size: 157 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. This is a general filing with limited metadata available.
Get daily alerts with 3 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 44 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC